Molecular Analysis of Endoscopic Cytology Samples Supernatant in Pulmonary Nodules
NCT05306912
Summary
Lung cancer screening is based on low dose CT scan (LDCT), a highly sensitive but poorly specific tool. Complementary specific approaches are thus strongly needed, among which cell-free DNA (cfDNA) genotyping has been proven highly specific but of low sensitivity (25 to 50% for stage I diseases) due to inconstant tumor shed. Tumor biopsy is thus often required and radial endobronchial ultrasound (rEBUS) bronchoscopy is a minimally invasive approach (\<3% complications) but of limited sensitivity in cases of nodules \< 20 mm. The investigators hypothesized that methylation analysis on cfDNA floating in supernatant derived from rEBUS specimens could improve rEBUS sensitivity
Eligibility
Inclusion Criteria: * rEBUS bronchoscopy planned for one, two or three ≤ 20 mm nodule * World Health Organization (WHO) Performance status 0-3 * Informed signed consent * Patient affiliated or beneficiary of a social security scheme (Social Security or Universal Medical Coverage). Exclusion Criteria: * Lung cancer diagnosed before the date of the procedure * Lung cancer strongly suspected due to mediastinal or extra thoracic lesions * Patient under State Medical Assistance * Patient deprived of liberty on administrative or judicial decision, or patient under guardianship, curators or safeguard of justice
Conditions3
Interventions1
Related trials
- Cancer of the Lung And SeneScencE - Prospective Cohort 1 — Assistance Publique - Hôpitaux de Paris
- Cardiovascular Outcome of Cancer Patients: The "GMEDICO Cohort" — Assistance Publique Hopitaux De Marseille
- Evaluation of the Effectiveness of Platelet-based and Microvesicle-based Assays to Predict Thrombotic and Bleeding Risk in Chronic Kidney Disease Patients With Acute Coronary Syndrome — Assistance Publique Hopitaux De Marseille
- Intrinsic Validity of Molecular Marker(s) Detection on Tissular Tumoral DNA to Predict the Efficacy of 177Lutetium-PSMA-617 (Lu-PSMA) Treatment for Castration-resistant Metastatic Prostate Cancer — Centre Jean Perrin
- LIQUID BIOPSY IN Low-grade Glioma Patients — University Hospital, Montpellier
- Memory Deterioration in Alzheimer Disease — Norwegian University of Science and Technology
- Multimodal Assesment of Alzheimer Patients — Norwegian University of Science and Technology
- Study of High Density Lipoprotein Function in Type 1 Diabetic Patients With Nephropathy — Centre Hospitalier Universitaire Dijon
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
NCT05306912